Detection techniques of circular RNAs as new biomarkers in systemic lupus erythematosus by Mihaylova, Galya et al.
Scripta Scientifica Pharmaceutica, 2020;7(2):7-13
Medical University of Varna 7
REVIEWS
DETECTION TECHNIQUES OF CIRCULAR RNAS  
AS NEW BIOMARKERS IN SYSTEMIC LUPUS 
ERYTHEMATOSUS
Galya Mihaylova1, Mariya Kosturkova2,3, Maria Radanova1,4
1Department of Biochemistry, Molecular Medicine and Nutrigenomics,  
Faculty of Pharmacy, Medical University of Varna, Bulgaria 
2Department of Propaedeutics of Internal Diseases, Faculty of Medicine,  
Medical University of Varna, Bulgaria 
3Clinic of Internal Disease, St. Marina University Hospital, Varna, Bulgaria 
4Clinic of General and Clinical Pathology, Laboratory of Molecular Pathology,  
St. Marina University Hospital, Varna, Bulgaria
Address for correspondence:  
Maria Radanova
Faculty of Pharmacy 
Medical University of Varna




Received: November 24, 2020
Accepted: December 9, 2020
ABSTRACT
Systemic lupus erythematosus (SLE) is severe, chronic autoimmune disease affecting mainly young active 
individuals, leading to disability and premature death. Recent studies have reported long non-coding RNAs 
(lncRNAs) to participate in the pathogenesis of the disease. Among lncRNAs, the circular RNAs (circRNAs) 
gain growing scientific attention due to their stability in body fluids. This makes them suitable for new non-
biomarkers for evaluation of SLE activity and promising therapeutic targets. Methods for detecting of cir-
cRNAs are evolving rapidly. The aim of this review is to present these techniques and their advantages and 
disadvantages.
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INTRODUCTION
Systemic lupus erythematosus (SLE) is the pro-
totype multisystemic autoimmune disease with а 
chronic course of remissions and exacerbations, 
leading in many cases to severe end-organ damage 
and substantial disability (1,2). Its etiology is com-
plex and includes environmental, hormonal, genet-
ic and epigenetic factors (3). Typical for the disease 
are vigorous autoantibody production, generation of 
immune complexes and immune-mediated tissue in-
jury (2,4). The clinical presentation can vary among 
patients from mild mucocutaneous or joint manifes-
tations to life-threatening renal or central nervous 
system involvement. 
Given this heterogeneity, SLE is a challenge 
not only to treat, but also to diagnose and monitor. 
That is why in recent years there has been an inten-
sive search of biomarkers for early diagnosis and for 
more accurate evaluation of disease activity. In the 
wide spectrum of biomarkers, non-coding RNAs 
(ncRNAs) appear to have the potential of being the 
ideal biomarker - specific, sensitive and noninvasive. 
ncRNAs are the dominant product of eukaryotic 
transcription and are associated with key biological 
processes and diseases. Generally, there are: 1) small 
non-coding RNAs (sncRNAs) with a length equal to 
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or less than 200 nucleotides and 2) long non-coding 
RNAs RNAs (lncRNAs) - with a length of over 200 
nucleotides (5). lncRNAs are involved in various im-
portant biological processes such as chromatin re-
modelling, gene transcription, RNA splicing and 
others. The functional consequences of a change in 
the expression of lncRNAs are large and pathogenet-
ically significant. Recent studies have shown that ln-
cRNAs are involved in the pathogenesis of immune-
mediated inflammatory diseases such as rheuma-
toid arthritis, autoimmune thyroiditis and SLE (6-8). 
This makes them suitable targets for therapy and al-
lows them to be studied as potential biomarkers for 
early diagnosis and assessment of activity in SLE (9-
12). Recently, a newly discovered type lncRNAs – cir-
cular RNAs (circRNAs) have received great scientif-
ic attention. They are resistant to exonucleases and 
have a stable structure, which prolongs their half-life; 
they also have a tissue-specific expression and a re-
lation to developmental stage or age abundance (13). 
Since а growing number of studies have revealed cir-
cRNAs as a potential clinical biomarker for SLE (14-
17) and for lupus nephritis (LN) (11, 18-20), their de-
tection is of great importance. Along with the in-
creasing knowledge about these RNAs, the methods 
for their detection are also being developed. The aim 
of this article is to review these techniques and pres-
ent their advantages and disadvantages.
METHODS FOR CIRCRNAS 
DETECTION
In the early studies, the detection of circRNAs 
has been achieved with electron microscopy (21). 
Nowadays, various techniques are used to detect cir-
cRNA expression and to investigate their functions. 
For example, by using RNA-Seq and microarray re-
searchers can identify circRNAs (22). Validation 
methods include polymerase chain reaction (PCR) 
(23), northern blot (24), in situ hybridization (25). Us-
age of enzymatic methods like RNase R and RNase 
H degradation assay is optional and helps researchers 
to achieve correct identification of circRNAs (26,27). 
Distinguishing between circRNAs and linear tran-
scripts is possible with 2D gel electrophoresis (28) 
and gel trap electrophoresis (29). In circRNA analy-
sis, several methods are combined for detection and 
validation of this type of lncRNAs. In this context, 
the order of the used detection methods often is as it 
follows: circRNA selection, RT PCR, Sanger sequenc-
ing (Fig. 1). 
Fig. 1. Workflows in circRNA analysis where different methods for detection and validation are combined.  
Total pool of RNA can be treated with RNase R and enriched with circRNAs for microarray or sequencing and subsequently data 
analysis. The amplification step is recommended when there is a low-input material. Next, for validation of circRNAs of interest real 
time PCR, northern blot or fluorescent in situ hybridization (FISH) can be used. Another strategy begins with electrophoresis - the 
separated circRNAs are then extracted, sequenced and validated. A third possible workflow starts with circRNA selection from avail-
able databases. They give an information about the circRNA sequence, network interactions, expression and disease-related data. 
PCR technique is the most frequently used one for validation of in silico-selected circRNAs.
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CircRNA Selection
CircRNAs can be selected from databases, mi-
croarray or RNA sequencing. High-throughput anal-
yses like microarray and RNA sequencing include 
prior treatment with RNase R for linear RNA reduc-
tion and enhancement of circRNA detection (30). If 
RNA sequencing is performed at high depth (100-150 
million reads), enrichment of circRNAs is not neces-
sary (31). Microarrays profile only known circRNAs 
through hybridization. While microarrays recognize 
circRNAs based only on the junction sequences, they 
do give information on the internal sequence of a 
given circRNA. Moreover, microarray cannot distin-
guish among circRNAs with common junction se-
quences (31). However, microarray offers good anno-
tation and analysis related to circRNA biology like 
miRNA binding sites (32). On the other hand, RNA 
Seq has limited annotation information and gener-
ates large data (32). At the same time, RNA sequenc-
ing has a higher discovery power and is recommend-
ed for the detection of novel circRNA transcripts (30) 
(Table 1). For circRNA detection from RNA-Seq data 
different bioinformatics tools are used. They can be 
divided into two groups: 1) with “pseudoreference-
based” or “candidate-based” strategy, when they re-
quire circRNA sequence with the gene annotation 
and 2) with “segmented-based” strategy, when they 
relay backsplicing junction identification from the 
mapping information generated by alignment of the 
reads to the reference genome or transcriptome (33). 
All computational approaches have their own advan-
tages and some authors find dramatic differences in 
their sensitivity (34). As a conclusion, computation-
al circRNA analyses are still being developed – still 
the choice of algorithm for the genome-wide detec-
tion of circRNA significantly impacts false positive 
and false negative rates of detection, and they need 
further development.
Many databases have been developed to 
facilitate circRNA studies. Some of them provide 
the sequences of given circRNAs or clarify circRNA 
position in the genome and expression pattern in 
tissues and cells (circBase); and propose a design 
of divergent primers and prediction of miRNA or 
protein targets (CircInteractome) (33).
Enzymatic Methods
Enzymatic methods are optional and often per-
formed in combination with other techniques since 
they provide circRNAs enrichment due to the en-
zyme-based depletion of linear RNA fragments 
(35,36,37). Limitations in exoribonuclease RNase R 
usage are related to incomplete efficiency of the en-
zyme and the possibility to introduce technical noise 
(37,38). It is possible that stable structures in linear 
RNAs block the enzyme action too.
Other less frequent enzymatic methods, which 
leave circRNAs but not most of the linear RNAs in-
tact, include RNase H (26), tobacco acid phosphatase, 
and terminator exonuclease treatment (35). When 
two short DNA probes are annealed to the RNA of 
interest, RNase H cleaves that RNA. Run on a gel and 
blotted for the fragments, the circular RNA of inter-
est appears as two bands. If RNA is cleaved in the 
presence of each DNA probe separately, circular spe-
cies are shown by one band (38). 
Usually, the enzymatic methods go before RNA-
seq, microarray or RT-PCR analyses in order for true 
circRNAs to be detected and quantified. Howev-
er, some linear RNAs such as snRNA can overcome 
the enrichment step and affect downstream analyses 
Microarray RNA Seq
Detect only known circRNAs Detect novel circRNAs
Principle of hybridization Principle of cloning & sequencing
High input of total RNA Low input of total RNA
Limited to the probes on the array May include linear RNAs resistant to RNase R
Relies on junction sequences and does not inform on 
mature sequences Does not inform on variants
Good annotation Still evolving annotation
Desktop computational resources Large data and high demand of computing power
Table 1. Comparison between microarray and RNA-seq in circRNAs detection 
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(37). To resolve this problem, Pandey et al. developed 
the so-called RPAD method, based on initial RNase 
R treatment followed by poly(A) tailing and poly(A) 
depletion (39).
PCR
The PCR technique is the speediest and most 
effortless detection method, which is usually used for 
validation of the selected by microarray or NGS cir-
cRNAs. Divergent and not convergent primer pairs 
are required for expression validation of the selected 
circRNAs (40). In comparison with convergent prim-
ers, divergent ones can amplify the circular form and 
are resistant to RNase R (41). There are already web 
tools for the design of divergent primers (42). Linear 
RNAs, such as GAPDH and β-actin, are usually used 
as internal control genes (43,44). There are several 
studies that have reported that circRNAs are better 
choice reference genes for the detection of other cir-
cRNAs (45). Zhong et al. suggest hsa_circ_0000284 
and hsa_circ_0000471 may be used as reference 
genes for circRNAs and for other RNAs, too (46).
Sanger Sequencing
When a not characterized or not yet validated 
circRNA is being analysed, Sanger sequencing of the 
obtained PCR product is recommended for final val-
idation (40). Sanger sequencing requires purification 
of PCR products using phenol/chloroform/isoamyl 
alcohol precipitation, and then the existence of the 
back-splice site is validated.
Northern Blotting
In general, the Northern blot starts with dena-
turation and separation of RNA samples by gel elec-
trophoresis. Agarose gels are recommended for cir-
cRNAs from 0.2 up to a few kb. However, if circu-
lar and linear RNAs have the same size, they can-
not be distinguished by their running behavior. In 
polyacrylamide gels circRNAs have mobility rela-
tive to linear markers, therefore these gels are suit-
able for circRNAs only up to 1 kb (24).  The separat-
ed RNA samples with different size are transferred 
and immobilized onto a membrane. Then a labelled 
probe against specific RNA sequences is hybridized 
with the membrane. After membrane washing and 
depending on the probe labelling, the hybrid signals 
are detected through different methods. The specif-
ic circRNA detection is determined: 1) by the choice 
of probe regions and the detection principle; 2) by 
the choice of a gel matrix (24). So, the design of the 
probe is one of the important steps in this analysis. 
The probe usually has 100-200 nt in length and could 
be selected against continuous exon region or against 
exon-exon junction. The exonic probe allows simul-
taneous detection of a linear transcript, thus their us-
age requires further validation of the circularity by 
RNase R, for example.
FISH
Visualization of different RNA species within 
the cells is allowed by fluorescence in situ hybridiza-
tion (FISH) (47). When FISH is coupled with high-
resolution microscopy it becomes a powerful meth-
od for analyzing the subcellular localization of RNA. 
However, the detection of circular RNAs (circRNAs) 
using microscopy is challenging since circRNA junc-
tion is the only target for the FISH probe in order to 
avoid linear RNA recognition (48).
2D Electrophoresis and Gel Trap Electrophoresis
For distinguishing circRNAs from linear RNAs 
two-dimensional denaturing polyacrylamide gel 
electrophoresis and gel trap electrophoresis can also 
be used. When total RNA is run on a 2D gel, circular 
and linear RNAs show different migratory patterns. 
Linear RNA migration is along the diagonal, whereas 
circRNA migration is off of the diagonal and resem-
bles an arc (28). circRNAs can be excised from the gel 
and used in next generation sequencing (NGS) as an 
enrichment step (49). In gel trap electrophoresis only 
linear RNAs migrate in the gel. CircRNAs are held in 
the well, thus forming the circRNA pool. It is possi-
ble for circRNAs to be extracted from the gel and se-
quenced via NGS (49).
CONCLUSION 
The functions of the majority of circRNAs are 
still unknown. However, circRNA detection and val-
idation are an initial step before biogenesis and func-
tional analysis. That is why the developing of these 
identification methods will give a precise way to ex-
plore the functional relevance of circRNAs that are 
involved in SLE pathogenesis as well as the opportu-
nity for these circRNAs to be used as biomarkers of a 
new generation.
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